Global Novel Therapeutics Using Microbiome for IBS Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 1054

  • Format: PPT, PDF

Global Microbiome Therapeutics Market by Type (Faecal Microbial Transplant [FMT], Drugs) By Application (C. difficile, Crohn’s Disease, Inflammatory Bowel Disease [IBD], Diabetes), and by Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America) – Opportunity Analysis, Trends, and Forecasts (2019 – 2028).


Report Overview

The global microbiome therapeutics market size was valued at USD $1.31 Billion in 2019 and is expected to grow to $XX billion at a CAGR of xx% through 2028.

Increasing prevalence of diseases due to dysbiosis of microbiota in the gut and provisioning of a high amount of funding for biological drug development studies are the key drivers affirming growth of this market.

Gut microbiome has been known to be associated with the good health of a person. Researchers have reported that alteration in a number of microorganisms such as firmicute, Bacteroidetes, and actinobacteria leads to the development of gastrointestinal disorders, diabetes, arthritis, and other neurological disorders. Heavy and long-term use of antibiotics, unhealthy lifestyle, and increasing age are some of the factors reducing the number of beneficial microorganisms in the human body.

Low level of beneficial microbiota helps the growth of fatal infectious diseases and organisms, such as Clostridium difficile (C. difficile) and ulcerative colitis. C. difficile has been reported to affect over half a million people in a single year and has a high recurrence rate. People on antibiotic treatment are 7 to 10 times more likely to get affected by C. difficile infection during the treatment and the months following it.

Increasing collaboration between pharmaceutical companies for development of novel drugs is also a high impact rendering factor for growth. For instance, Seres Therapeutics, U.S., and Nestlé Health Science have entered into a collaborative agreement for development and commercialization of extensive product pipeline for ulcerative colitis and C. difficile infection.

Market Drivers

The market is driven by the growing prevalence of chronic diseases and robust pipeline. In addition, growing prevalence of chronic diseases is anticipated to boost the growth of the market as well. The human microbiome therapeutics market analysis includes application segment and geographic landscapes.

1. Global Novel Microbiome Therapeutics Market Overview…………………………….
A. Market Size
2. Market Growth Drivers……………………………………………………..……………….
A. Increasing base of target population
B. Increasing research funding
C. Rising awareness
D. Strong product pipeline
3. Market Restraints.………………………………………………………………………….
A. High cost
B. Penetration & growth prospect mapping
4. Microbiome Therapeutics Market Segmentation…………….…………………………..
A. By Type
I. Faecal Microbial Transplant
II. Drugs
B. By Application Type
I. Clostridium difficle infection
II. Crohns disease
IV. Diabetes
V. Others
C. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Latin America, Middle-East and Africa Market Analysis
5. Microbiome Therapeutics Major Drugs Market Share……………………………….
A. Market Analysis, Insights and Forecast by revenue
6. Competitive Landscape………………………………………………………….………..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………….
A. MicroBiome Therapeutics LLCCompany overview, Product & Services, Strategies & Financials
B. Seres Therapeutics Company overview, Product & Services, Strategies & Financials
C. Enterome Bioscience Company, Product & Services, Strategies & Financials
8. Potential Growth Opportunities………………………………………………..…………
A. Advancements in drug development
B. Untapped markets in developing economies
9. Factors Driving Future Growth…………………………………………………………..
A. Key Industry Developments of Novel Therapeutics using Microbiome
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type:

On the basis of type, therapeutics are segmented into Fecal Microbial Therapy (FMT) and microbiome drugs. FMT has been reported to be used off label by physicians since the early 90s, until it received biological therapy Investigational New Drug (IND) approval recently for its usage in the treatment of C. difficile patients.

FMT dominated the market in 2019 with a substantial share. It is the only therapeutic option available in the market, which affirms the dominance of this segment. Moreover, increasing research activities undertaken by research institutes for finding more therapeutic applications of FMT and introduction of FMT capsules are expected to accentuate growth.

Drugs are anticipated to witness highly lucrative growth over the forecast period due to factors like presence of strong product pipeline with more than 27% drugs in phase 2. Key players are expecting high revenue generation from lead drugs, such as NM504, EB 8018, SER-109, and SGM- 1019.

By Application Type:

Microbiome therapeutics find wide applications in various fields, some of which are C. difficile infections, Crohn’s disease, Inflammatory Bowel Disease (IBD), and diabetes. Amongst all, C. difficile held the largest market share of over 40.0% in 2019, which can be solely due to the approval of FMT for use in the treatment of C. difficile under IND approval.

On the other hand, Crohn’s disease is expected to be the fastest growing application for microbiome therapeutics. More than 20% of drug pipeline consists of therapies for the treatment of Crohn’s disease. Other applications, such as treatment of lactose intolerance, are estimated to witness potential growth over the forecast period with the commercialization of drugs such as RP-G28 after 2019.

By Region:

North America dominated the regional market with revenue generation of over USD 15.0 million in 2019. Highly established research facility for the development of novel therapeutics, presence of health-conscious population, and rising healthcare expenditure are the major factors for dominance of the region. Moreover, local presence of key players, such as OpenBiome, in this region will help in maintaining this dominance over the forecast period.

North America is closely followed by Europe with a difference of merely 9.0% in the market share. However, Asia Pacific is estimated to witness growth with a CAGR of over 49% due to factors such as increasing economic stability, high amount of biological research initiatives in national institutes, and growing awareness among physicians regarding novel therapeutics.

Top 5 Major Players

Some of the major companies are MicroBiome Therapeutics LLC; Seres Therapeutics; Enterome Bioscience; MaaT Pharma; Rebiotix, Inc.; Ritter Pharmaceuticals; Second Genome; and OpenBiome. Key players are receiving heavy funding from other companies to support the development of microbiome therapeutics pipeline. For instance, Seventure Partners, a venture capital firm, has recently announced to have invested more than USD 160 million for research in this segment.

Companies are undertaking strategic initiatives such as new product development and venture capital investments for catering to greater opportunities in both developed and developing countries. Key players are also investigating drug molecules with more than one application for gaining wider market share. RP-G28 by Ritter Pharmaceuticals, which is currently in clinical trials for lactose intolerance, is also being investigated for future indications such as Crohn’s disease, ulcerative colitis, and irritable bowel syndrome.


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements